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Abstract: 
A synthetic route to a mycosamine donor was designed and provided access to a set of AmB 
derivatives targeted to probe the effect of the C2′-OH. It was determined that the configuration of 
the C2′-position is inconsequential but that O-methylation of this alcohol was deleterious to its 
mode of action. Additionally, the analog incorporating a mycosamine derivative from the 
enantiomeric series was devoid of activity. 
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Article: 
The drug of choice for hospital patients with systemic fungal infections is amphotericin B (AmB, 
1, Figure 1). Yet, the full details concerning its mode of action remain elusive despite efforts 
over four decades.(1) Indeed, there is a plenum of questions unanswered concerning the 
remarkable ability of this small molecule to undergo self-assembly and recognition in lipid 
bilayers. This becomes even more significant given the fact that AmB has been found to have 
activity in treating Alzheimers, Creutzfeldt−Jakob, and HIV infections, wherein it has been 
suggested that AmB/protein interactions may be relevant. A number of derivatives and closely 
related structures have been isolated,(2) biosynthesized,(3) and accessed by total synthesis.(4, 5) 
These have been used to probe the role of the various functional groups in the mode of action, 
including the hydroxyls along the C1−C12 spine, the polyene,(6) and carboxylic acid.(7) 
Carbohydrates appended to natural products are increasingly being recognized as critical to their 
activity.(8) Yet, despite the fact that mycosamine is a highly conserved moiety in the family of 
polyene macrolide antibiotics, no studies have been directed at understanding its effect on yeast 
at a resolution that focuses on the individual functional groups. Herein we document an initial 
investigation of the role of the mycosamine C2′-OH on the fungicidal activity of AmB. In the 
course of our studies, we have observed that the relative configuration at C2′ is not a determinant 
for activity, and yet the corresponding C2′-methyl ether analog is 50-fold less effective (Figure 
1). Interestingly, the preparation of AmB that incorporates the ent-C2′-epi-mycosamine displays 
100-fold decreased activity in yeast. These results implicate a key role for mycosamine in AmB 
wherein the aminosugar is not merely a polar headgroup and, importantly, whose role is more 
significant than merely forming a hydrogen bond to sterols residing nearby. 
Figure 1 is omitted from this formatted document. 
The early literature of AmB describes simple derivatives at the C-16-CO2H and mycosamine-
NH2 that provide some indication of their importance.(1) For example, AmB methyl ester (AmE, 
2) is equipotent to AmB in yeast (AmB = 0.30 μM and AmE = 0.25 μM), but mycosamine N-
acetamides are inactive, leading to the suggestion that a basic amine at C3′ is necessary.(9) 
Caffrey has determined that the aglycone of AmB is inactive, thus underscoring the relevance of 
the aminosugar itself.(7) Moreover, we have shown that amphotericin B incorporating N,N-
bis(aminopropylene) derived mycosamines display enhanced fungicidal activity and possess an 
improved therapeutic window.(10) 
 
An interaction involving mycosamine C2′ and ergosterol hydroxyl groups was suggested some 
time ago to be critical in enabling the sterol to stabilize the putative barrel-stave pore in fungal 
membranes.(11) More recently, studies have been conducted with conformationally rigidified 
analogs in which short hydrophobic tethers linked the mycosamine amine with the C-16 
carboxylic acid.(12) It is well worth noting that the calculated conformation for the three 
structures prepared and analyzed did not correlate to the most stable conformation relating 
mycosamine and the macrocycle, discussed in detail below. Despite the intriguing aspects of this 
model the role of C2′-OH has not been experimentally explicitly tested with derivatives that do 
not extensively alter the mycosamine or its relationship to the macrocycle. We therefore 
designed analogues that would directly probe the putative H-bonding interaction between 
mycosamine and ergosterol and further map out subtleties of the mycosamine subunit on the 
activity of the polyene macrolide antibiotic AmB. In approaching the problem, we decided to 
take a course of action that minimized the perturbations of the mycosamine itself. Thus it was 
our intention to maintain the overall polar and structural characteristics of the parent sugar. 
 
We have described an improved glycosidation method for the AmB aglycone in the context of a 
synthesis of C-35 deoxyAmB.(13, 14) The approach relies on the use of the C2′-mycosamine 
epimer as a donor because of exquisite anomeric control that ensues in the coupling reaction. 
Thus, the route enables rapid access to C2′-derivatives and provides a point of entry for studies at 
this locus. Consequently, our investigation was designed to develop a general approach to the 
mycosamine platform (Scheme 1). The synthesis commences with the conversion of 2-
acetylfuran 3 to allylic alcohol 4 in five steps following the route developed by O’Doherty.(15) 
This resulting alcohol was engaged in a directed epoxidation reaction and subsequently protected 
to afford epoxide 5. The synthesis of the mycosamine donor analog was completed by epoxide 
opening with azide, acylation of the resultant alcohol, and generation of the corresponding 
trichloroacetimidate (8), whose configuration was established by comparison to previously 
synthesized donors.4 The synthesis route is shorter than any previously described(14a) and, more 
importantly, allows for facile manipulation of different groups of the sugar. 
Scheme 1 is omitted from this formatted document.  
A semisynthetic route that commences with the natural product was relied upon to access a 
suitably protected aglycone (Scheme 2).(7b) AmB was subjected to amine protection (Fmoc); 
esterification (C16-CO2H → C16-CO2Me); and methyl ketal formation to yield 9. Subsequent 
silylation of the nine alcohols, oxidative cleavage of the sugar, and diastereoselective C═O 
reduction complete the synthesis of alcohol 10. 
Scheme 2 is omitted from this formatted document. 
Mycosamine donor 8 was coupled to aglycone 10 to produce a mixture of the glycosylated 
product (Scheme 2), along with an orthoester, which is a well-known coproduct of the 
glycosidation of the hindered secondary alcohol. These are conveniently separated by 
chromatography on silica gel, following alkaline cleavage of the C2′-acetate. The glycosylated 
products were subjected to global deprotection to provide AmB analog 11 (C2′-epi-AmE), 
incorporating the C2′-epimer of the mycosamine. Alternatively, the C2′-OH was subjected to O-
methylation after acetate cleavage, which following deprotection provided 12 (C2′-epi-C2′-OMe-
AmE). Coupling of the aglycone to (±)-8 provided access to 13 (C2′-epi-ent-mycosamine-AmE), 
which is the C2′-epi isomer derived from the unnatural ent-mycosamine. 
 
With analogs 11−13 in hand, their growth inhibition activity against Saccharomyces cerevisiae 
(BY4741) was assayed (Figure 2). The C2′-epimer (11) displayed activity equivalent to AmE 2 
(0.30 μM for 11 and 0.25 μM for AmE). To further understand analog 11, it was subjected to a 
liposome assay which we have utilized to measure potassium efflux. In the assay 11 was 
indistinguishable from AmE (2) in the presence of cholesterol and ergosterol (see Supporting 
Information). Thus, the configuration at C2′ is not a major determinant for activity in either yeast 
or liposomes. This result is significant because it questions the models in which the C2′-alcohol 
forms a hydrogen bond with the ergosterol that is critical for channel formation (Figure 3).(11, 
16) It is well worth noting that the only experimental study examining this hypothesis relied on 
covalently tethered, conformationally restricted derivatives of AmB whose activities in yeast and 
liposomes failed to correlate altogether.(12) Additionally, in these models the calculated minima 
for the conformationally restricted analogs do not correspond to the low energy minima 
calculated by Borowski.(11) In the low energy conformer, the C(1′)−O−C(19)−C(18) dihedral of 
−60° minimizes the unfavorable steric interactions between the sugar and polyene backbone, and 
the C(2′)−C(1′)−O-C(19) dihedral subtends an angle of 180° as a consequence of the 
exoanomeric effect (Figure 3). 
Figure 2 is omitted from this formatted document. 
Analysis of the model in light of the results with C2′-epi-mycosamine is revealing. The structure 
illustrated for mycosamine in Figure 3 corresponds to the lowest energy conformer. In the model 
that is commonly invoked, the axially disposed C2′-OH (X in Figure 3) is engaged in H-bonding 
to the hydroxyl group of ergosterol. This interaction is proposed to bring the steroid in proximity 
to the macrolide heptaene, thereby stabilizing the integrity of the channel. The fact that the C2′-
epi diastereomer (Y = OH in Figure 3) displays similar activity cannot be reconciled with this 
model, because the corresponding interaction in the C2′-epi series would necessarily move the 
steroid substantively further away. 
 
We next proceeded to examine the C2′-methyl ether derivative (12). It was found to be 
approximately 50-fold less active than 2 and 11. The methyl ether group precludes the possibility 
for the C2′-position to act as a hydrogen-bond donor altogether. This observation is intriguing in 
light of the results indicating the insignificance of the configuration at C2′. We subsequently 
examined the analog incorporating the mycosamine derivative from the enantiomeric series. 
Analog 13 was essentially inactive (MIC95 > 20 μM). This is interesting because the equatorial 
disposed substituents of the mycosamine in analogs 11 and 13 occupy similar spatial dispositions 
relative to the pyran ring (Figure 2). However, further scrutiny reveals significant differences in 
the conformational profile of the two diastereomers. Analysis of models of 11 and 13 suggests a 
key difference with respect to the spatial disposition of the enantiomeric mycosamine derivative 
relative to the macrocycle (Figure 4 and Supporting Information). In the current study, the lack 
of activity of 13 when contrasted to 11 is consistent with conformer 11′ as critical for activity. 
Analysis of a conformer of 13 that maps onto 11′ (see 13′′ in Figure 4) reveals that it suffers from 
destabilizing double gauche pentane interactions between C2′-OH and C-20 of the macrocycle, 
in addition to positioning of the polar amine into the lipophilic membrane of the putatively 
formed pore. 
Figures 3 & 4 are omitted from this formatted document. 
In summary, a synthetic route to mycosamine donor 8 provided access to a set of mycosamine 
derivatives targeted to probe the effect of C2′-OH on the biological properties of AmB. A key 
observation in this study is that the configuration of the C2′-OH is inconsequential to the activity 
of the polyene macrolide in yeast and liposomes; however, O-methylation of this alcohol was 
significantly deleterious. Additionally, the analog incorporating a mycosamine derivative from 
the enantiomeric series was devoid of activity. Collectively, the results underscore the fact that 
the mycosamine subunit is not merely a polar group and that the theorized lowest energy 
conformation by Borowski is critical for full expression of the biological activity in yeast. The 
active conformation is one which incorporates an exoanomeric stabilization and minimization of 
steric effects between the mycosamine and the polyene backbone. Further structure−activity 
relationships involving the mycosamine are currently under investigation. In general any 
attempts at exploring structure−activity relationships ultimately must contend with the prospect 
that the fundamental structure has been altered; in a broader sense the work we have delineated 
underscores the possibilities in utilizing stereochemical probes to gain insight into the biological 
mode of action with relatively minimal structural perturbation. 
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